Yüklüyor......
The pharmacogenomics of drug resistance to protein kinase inhibitors
Dysregulation of growth factor cell signaling is a major driver of most human cancers. This has led to development of numerous drugs targeting protein kinases, with demonstrated efficacy in the treatment of a wide spectrum of cancers. Despite their high initial response rates and survival benefits,...
Kaydedildi:
| Yayımlandı: | Drug Resist Updat |
|---|---|
| Asıl Yazarlar: | , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2016
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5022787/ https://ncbi.nlm.nih.gov/pubmed/27620953 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.drup.2016.06.008 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|